Bellerophon Therapeutics Company

Bellerophon focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary diseases.


Connections from

Technology: Cancer
Headquarters: Warren, New Jersey, United States
Investment Stage: N/A
Number Of Exists: N/A
Founded Date: 2009
Industry: PharmTech
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Investor Type: N/A
Funding Status: IPO